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Objective: Identify by integrated 
review the main result indicators 
in the process of organ donation 
and transplants used in Brazil and 
worldwide. The integrated review of 
this literature was performed on bibli-
ographic database MedLine/PubMed 
and LILACS and governmental and 
non-governmental sites between 1995 
and 2011. The describers/keywords 
used were organ donations, organ 
transplant and results in health, being 
selected 26 articles and nine sites. The 
evidence level classification in the arti-
cles changed from one to six. Results: 
The evidence level in the articles in its 
totality was 66.6% was four (12:18 
PubMed) all the articles of LILACS 
database (8). The indicators showed 
in the articles intends to evaluate, 
assess, measure and control data re-
lated to the profile of the donor, clini-
cal and hospital conditions, ischemia 
timing, organ size, surgical procedure 
and the complications that came from 
transplants.
AbstrAct
Keywords: indicators; organ trans-
plantation; transplants.
IntroductIon
In 2011, Brazil had more than 10 
donors per million population for the 
first time in its history. The number 
of 11.4 donors per million population 
added up to over 23,000 transplants 
performed in the public health care 
system. The number of patients wai-
ting for a transplant decreased by 
23% in 2011 in relation to 2010. The 
most significant decreases were seen 
in the liver (42%), cornea (39%), and 
pancreas (36%) waiting lists. Lesser 
decreases were observed in the kidney 
(14%), heart (13%), and lung (5%) 
lists, recently targeted alongside liver 
transplants by public policies.1
Information on reporting rates, 
donations, failed overall and 
categorized donations broken down 
in terms of transplants not authorized 
by the subject’s family, unconfirmed 
brain death, medical contraindication, 
cardiorespiratory arrest, and inade-
quate infrastructure is widely avai-
lable. Reports have been published 
by non-governmental organizations 
based on data voluntarily provided 
by transplant teams and State Centers 
for the Procurement, Distribution, 
and Transplantation of Organs and 
Tissues, possibly introducing bias in 
the analyses offered by their authors.
Despite the magnitude of the job 
done by public transplant institutions 
in Brazil, the Brazilian National 
Transplant System is facing severe 
operating issues. Some have been 
described in a report published by the 
Federal Accounting Court. The report 
contains detailed accounts of problems 
in areas such as management, quality 
control, and technology linked to 
medical procedures and the provision 
of timely treatment in equal terms to 
the target audiences of the National 
Transplant System.2
Additionally, issues such as the 
precarious information systems used in 
state transplant coordination offices, 
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the lack of communication of protocols related 
to organ procurement and donation to medical 
doctors, the non-existent or barely effective 
intra-hospital transplant committees, and the hi-
gh loss of donors and potentially transplantable 
organs are worthy of consideration.3 Indicators 
can be used in this context to help assess the 
performance of organ and tissue donation and 
transplant services.3
The purpose of indicators is to measure 
qualitative and quantitative aspects of variables 
such as the environment, structure, processes, 
and outcomes. Indicators cannot be construed 
as direct measurements of quality. Instead, they 
point out to what requires the attention of the 
assessed health care organization.
Indicators are units that allow the measurement 
of cases, events, and quantitative elements, and 
the verification of qualitative elements. Therefore, 
an indicator is a measurement tool used to survey 
the quantitative and qualitative aspects of a given 
phenomenon in order to assess it and substantiate 
the making of informed decisions. Indicators are 
derived from samples, and their validity depends 
on the good quality of the sampling process.4,5
In order for an indicator to be measurable, 
the following attributes must be considered: 
validity, i.e., how much the indicator can 
identify situations requiring improvements; 
sensitivity to indicate whether a process pre-
sents problems; specificity to set apart only the 
cases in which problems are occurring; simpli-
city; possibility to calculate and analyze data; 
objectively defined goals; and low-cost applica-
tion to allow it to be used routinely in health 
care institutions.4,5
Indicators are designed to provide data to 
be used in quality improvement initiatives and 
to enhance the transparency and clarity of the 
available information.5,6
The authors considered the difficulties 
experienced in organ and tissue donation and 
transplant services and the need to monitor, assess, 
and manage related processes, and designed a 
study to find the main indicators used globally in 
donation and transplant organizations. This study 
aimed to analyze the indicators used in donation 
and transplant services.
Objectives
•	 To review the outcome indicators used 
globally in organ donation and transplant 
services.
•	 To propose outcome indicators for the 
organ donation and transplant processes 
used in Brazil.
Methods
This integrative review followed the six steps 
required in this type of research: 1) identification 
of a theme and selection of the research ques-
tion; 2) definition of the study inclusion and sample 
selection criteria; 3) definition of the information 
considering all common characteristics and the re-
presentation of the selected studies; 4) assessment 
of the studies and critical analysis of study fin-
dings; 5) interpretation of results; and 6) presen-
tation of a review clearly reporting the identified 
findings.6,7
The search for papers included publications 
indexed on databases MedLine/PubMed and 
LILACS, to retrieve the references and abstracts 
of studies published in the Latin American and 
international literature. Online reports from 
government and non-governmental organizations 
were also included. The search was not limited to 
papers published within a specific period of time.
Studies were selected based on the following 
inclusion criteria: all paper types (original studies, 
literature reviews, update papers, research papers, 
case reports etc.); papers with abstracts and com-
plete text available for analysis; papers published 
in Portuguese, English, or Spanish by 2011; and 
papers in the area of health sciences with titles 
and/or abstracts with the following keywords: 
organ donation, transplants, indicators.
Titles and abstracts were considered first in 
paper selection. Papers meeting the question and 
purposes of the study were read in full, and had 
their methods and relevant results analyzed.7
After all papers had been read, they were 
categorized in terms of level of evidence. Level 
one - evidence obtained through meta-analysis 
of randomized controlled trials; level two - evi-
dence gathered from experimental studies; level 
three - evidence derived from quasi-experimental 
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studies; level four - evidence emerging from des-
criptive studies or qualitative approaches; level 
five - evidence from case or experiment reports; 
and level six - evidence based on expert opinions 
or legal documents.8,9
The following data were gathered on the 
selected papers: author, year of publication, 
country of origin of the study, source, study 
design, method, and relevant results. Frequently 
found indicators that met this study’s purposes 
were listed.
Next, indicators related to donation and 
transplant processes were assigned to their 
respective groups.
results
Nineteen papers were selected from MedLine/
PubMed for their titles and abstracts, and 18 were 
included in the study after the entire papers were 
read. Eight papers from LILACS were included, 
along with six government and non-governmental 
databases.10-33
The oldest paper listed on MedLine/PubMed 
dated from 1995. No other papers published 
between 1995 and 2000 were found. Thus, only 
this paper from 1995 with level 5 evidence was 
included. One paper with level 4 evidence was 
published in 2000, and two in 2001.10-14,24-30 No 
papers were published in 2002. Two papers were 
listed as published in 2003, with evidence levels 
4 and 5. In 2004 and 2005, only one paper was 
found for each year with level 4 evidence. Three 
papers were published in 2006, with evidence 
levels 4 and 6. In 2007 and 2008, two papers 
with level 5 evidence were published. In 2010 
only two papers with evidence levels 4 and 5 
were found.
Most of the papers published between 1995 
and 2010 (66.6%; 12:18) were case reports or 
experimental studies (level 4 evidence) and 33.4% 
(6:18) were descriptive studies. Eighty-nine 
percent of the papers included in this study were 
published in the United States.
The earliest publication on LILACS dated from 
2005, a paper with level 4 evidence. One paper 
with level 4 evidence was published in 2006. No 
records of papers published in 2007 were found. 
Five papers were published between 2008 and 
2010. All papers listed on LILACS and 67.0% of 
the studies carried out in Brazil published between 
2005 and 2010 had level 4 evidence.3,15-18,31-33
Two online databases were found in the 
United States, one in the United Kingdom, 
one in Canada, two in Europe, one in Spain, 
one in China, and one in Brazil. Five were 
maintained by government agencies and four by 
non-governmental organizations.19-23
When indicators related to the organ donation 
process were grouped (Chart 1), they were found 
to relate mostly to donation potential, donor 
profile, and organ quality. The identified indi-
cators were designed to measure the number of 
donors, donor characteristics, and organ quality 
by monitoring distribution systems, donor length 
of hospitalization at an intensive care unit, and 
cause of brain death.
Some of these indicators had been used for 
years in Brazil. The Brazilian Association for 
Organ Transplantation publishes quarterly 
reports featuring the data collected based on the 
following indicators:
•	 Number of processed potential donors;
•	 % organs offered and accepted;
•	 Rate of brain death reporting;
•	 Estimated potential number of donors 
(coroner’s office);
•	 Characteristics of brain death cases per 
year.
Transplant indicators (Chart 2) were more 
related to graft survival, time on the waiting list 
until transplantation, survival rates, and perfusion 
times. These indicators monitor organ quality, 
patient and graft survival. In Brazil, indicators 
connected to survival and time on the waiting list 
are currently used.
dIscussIon
This integrative review showed that database 
keyword-based searches identified the largest 
number of papers connected to donation and 
transplant. However, after titles and abstracts were 
read the number fell to 18 on MedLine/PubMed 
and eight on LILACS.
J Bras Nefrol 2013;35(3):220-228
Outcome indicators in the organ donation and transplant processes
223
chArt 1 MAin indicAtORs identified On Medline/PubMed, lilAcs, gOveRnMent And nOn-gOveRnMentAl  
 ORgAnizAtiOn dAtAbAses cOnceRning the dOnAtiOn PROcess
PubMed
Shehy E et al.;10 
Rithalia A;11 
Barber K et al.;12 
Hernandez et al.;13 
Zheng et al.14
• Number of donors; 
• Number of potential donors successfully processed; 
• Donor profile; 
• Donor clinical status; 
• Organ quality; 
• Distribution time; 
• % offered and accepted organs; 
• Causes for brain death.
LILACS
Marinho A;3 
Mattia NL de et al.;15 
Reis, DJFdos;16 
Solar P et al.;17 
Mesa et al.18
• Donor ICU hospitalization length; 
• Causes for impeded organ donation; 
• Brain-death reporting rates; 
• Estimated potential donors (coroner’s office); 
• Estimated yearly availability of organs and tissues; 
• Potential brain-death cases per institution; 
• Donor age (% and mean); 
• Cause of death; 
• Occupation and family income; 
• Donor family satisfaction.
Government and non-governmental organizations
Organización Nacional de Transplantes;19,20 
Registro Brasileiro de Transplantes.21-23
• Number of organs per age; 
• Number of organs per blood type; 
• Organ origin; 
• Number of organs per center; 
• Number of cases of brain death per institution; 
• Death characteristics per year; 
• Death characteristics per age.
chArt 2 MAin indicAtORs identified On Medline/PubMed, lilAcs, gOveRnMent And nOn-gOveRnMentAl  
 ORgAnizAtiOn dAtAbAses cOnceRning the tRAnsPlAnt PROcess
PubMed
Pacheco Z et al.;24 
Moreno A et al.;25 
Carbajal H, Cabriales H;26 
Atlés et al.;27 
Reese et al.;28 
Svyeder et al.;29 
Werterm et al.30
• Perfusion time; 
• Cost of transplantation; 
• Individual surgical risk; 
• Time on waiting list; 
• Risk of graft failure; 
• Organ characteristics; 
• Risk of infection; 
• MELD score for liver transplant recipients.
LILACS
Lima FET et al.;31 
Freire MP;32 
Fusco CC et al.33
• Time on waiting list; 
• Death rate of patients on the waiting list; 
• Survival rate; 
• Risk of infection; 
• MELD score for liver transplant recipients.
Government and non-governmental organizations
Organización Nacional de Transplantes;19,20 
Registro Brasileiro de Transplantes.21-23
• Time on waiting list; 
• Survival rate; 
• Rate of infection.
Two thirds (66.6%) of the papers on MedLine/
PubMed and LILACS had level 4 evidence, and 
none had evidence levels 1, 2, 3, or 6.
Significant development is needed in the 
organ donation and transplant services in Brazil, 
particularly in what concerns the quality of the 
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return over the funds invested through health care 
public policies.34-39
Nonetheless, this fact is not an excuse for 
the lack of studies on quality indicators, nor for 
the published literature’s low levels of evidence. 
One might infer that the Brazilian culture is not 
very appreciative of assessment processes, in an 
attitude that affects the willingness of officials 
and managers to establish indicators to measure 
the correlations between funds invested and the 
quality of processes and their outcomes.
Indicators are measurement tools used to 
survey the quantitative and qualitative aspects 
of a given phenomenon in order to assess it and 
substantiate the making of informed decisions.40-43
The use of indicators allows the capturing of 
trustworthy data connected to the phenomenon 
targeted in the assessment, and the identification of 
factors and situations impacting the process. And 
there lies the importance of employing indicators 
in the organ donation and transplant services to 
aid in the identification of improvement opportu-
nities. However, this review found a very limited 
number of studies in which valid indicators we-
re used to assess organ donation and transplant 
services.
Ongoing performance assessment of organ 
donation and transplant services favors the 
establishment of strategies conducive to process 
improvements. And improvements lead to better 
quality organ and tissue donation processes.44-46 
Quality can be gauged by monitoring process 
outcomes and assessing indicators.47-50
Countries such as Spain, Portugal, and the 
United States have given significant strides to 
develop this area and have seen increases on 
the number of donors. Conversely, catastrophic 
results have been reported in countries such as 
India, China, and others.19,51-56
In 2009, 6,490 reports of potential donors 
were made (34.2 pmp/year), but only 1,658 came 
through and 4,832 were missed. In 2010, 6,842 
potential donations were reported (36.4 pmp/ye-
ar), only 1,920 were processed, and 4,922 were 
missed. In 2011, 7,233 reports were made, on-
ly 2,048 donors came through, and 5,185 were 
missed.1,21,22 This data supports the information 
published in this study, as 67.0% of the papers 
included in the LILACS database described mat-
ters pertaining to the Brazilian organ donation 
and transplant scene. However, the indicators 
referred to in these studies were not properly 
validated, and cannot be used to effectively assess 
donation and transplant processes.
Brazil, as many other countries,34,36,38,57,58 
has not implemented valid indicators  to assess 
organ donation and transplant processes, which 
often prevents the identification of possible flaws 
and implementation of process improvements. 
However, some of the presented indicators (Charts 
1 and 2) have been used for years in Brazil. In the 
United States, organ procurement organizations 
(OPOs) monitor the steps of the organ and tissue 
donation processes and donor loss causes through 
performance indicators.34,38,59-61
PubMed had more publications (Charts 1 
and 2) on indicators for organ donation and 
transplant services. When donations were 
considered separately, the papers on LILACS had 
more indicators described. Thus, it is possible to 
realize the effort being made in Brazil to develop 
and validate indicators for organ donation and 
transplant processes.
Most transplant indicators have been described 
in papers published on MedLine/PubMed, with 
89% of them being proposed in papers written 
in the United States, reinforcing the efforts to 
develop and validate indicators to monitor not 
only the donation process, but also the quality of 
the transplants performed.
The scarce donor populations, the low rates of 
successfully processed potential donors, and the 
increasing number of patients entering transplant 
waiting lists every year call for decisive action by 
government and non-governmental organizations 
and health care workers in the search for new 
strategies and tools to enhance the management 
of the organ and tissue donation system. Each of 
the steps involved in this complex process has to 
be exhaustively and systematically assessed on 
an ongoing basis so that possible shortcomings 
are identified and proper corrective action is 
taken.62,63
Following this perspective (Chart 1), it was 
clear on PubMed that organ donation indicators 
were mostly geared towards potential donor 
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profiles and their clinical statuses (length of 
hospitalization, intubation, and others). In addi-
tion to these factors, the papers on LILACS 
included social, demographic, cultural, religious, 
and patient family satisfaction levels with the 
process.
Government and non-governmental organi-
zation databases had indicators concerned with 
territorial factors and patient death. The issues 
faced by many countries in the donation process, 
particularly Brazil, include underreporting (va-
rying depending on the region of the country 
considered), and loss of potential donors due to 
poor organ management or families refusing to 
authorize the donation.1,21,64-67
Thus, it may be suggested that once the 
indicators (Charts 1 and 2) found in the reference 
databases included in this integrative review have 
been validated, they may help decision-makers 
monitor and assess organ donation processes.68-70
The use of these indicators would make it 
possible to identify which health care institution 
is underreporting potential donors and which 
has been more effective at generating potential 
donors. Additionally, the assessment of donor 
clinical conditions could lead to more effective 
donor management procedures and more viable 
organs for transplantation.
Transplant indicators found on PubMed 
(Chart 1) took into account organ varia-
bles such as time of ischemia, size, and organ 
characteristics. Factors connected to surgical pro-
cedures and complications were also identified by 
these indicators.
The indicators on LILACS revolved around 
waiting time management, survival, and 
complications related to the process.
In order to improve the donation and 
transplant process success rates, the authors of 
the studies included in this review recommended 
reporting as many potential donors as possible, 
identifying the reporting potential of health care 
units with significant numbers of cases of brain 
death, and perform proper potential donor 
management.70-73
By their turn, distribution systems have to 
be designed to take into account time, organ 
ischemia, and the satisfaction of the family as 
the donor is returned to them after the organ 
donation has been completed.
The main recommendations related to 
transplants were connected to assessing organ 
conditions, time of organ ischemia, factors related 
to the transplant recipient, graft survival, and 
recipient quality-of-life.3,24-33 Studies on transplant 
indicators considered the need to minimize time 
of organ ischemia and the importance of produ-
cing better graft survival. These indicators may 
lead to improvements on surgical procedures, but 
focused more specifically on conditions connected 
to organ status and organ management until the 
transplantation.
The need to increase the number of donors 
is a global issue.74 One million people need 
transplants, and fewer than enough donors are 
available. Indicators are therefore needed to 
identify opportunities for improvement in the 
donation and transplant processes. Countries 
such as Spain, Portugal, Italy, the United States, 
to name a few, have significantly changed this 
scenario.36-38,41,42,58-62
Waiting lists mirror the need for transplants, 
and donation statistics show the losses of potential 
donors and the transplant opportunities missed 
every year. Indicators need to be validated so 
that quality programs can be implemented in the 
Brazilian organ donation and transplant services.
Countries such as the United States already 
count on effective indicator-based performance 
monitoring programs. Interestingly, 67.0% of 
the papers on performance indicators found 
in this study were published in the USA. In the 
United States, the information collected by 
the Organ Procurement and Transplantation 
Network (OPTN) is turned into indicators that 
are followed and assessed to aid in the develo-
pment of process improvement strategies. The 
OPTN is a public-private partnership whose 
primary goals are to increase the effectiveness 
of the organ procurement process, foster princi-
ples of equality in the national organ allocation 
system, and augment the supply or organs for 
transplantation.36,38,59-62
Spain, also a leading country when it comes 
to organ donation services with a rate of 34 
pmp, installed quality assurance programs 
J Bras Nefrol 2013;35(3):220-228
Outcome indicators in the organ donation and transplant processes
226
in all potential donor generating health care 
institutions, after carefully analyzing their perfor-
mance through indicators.57,74-77
Considering the significant number of indicators 
published in the literature, it was clear that organ 
donation and transplant process improvement 
initiatives have recently grown to offer methods, 
tools, and indicators to help government officials, 
non-governmental organizations, and society 
identify opportunities for improvement.
closIng reMArks
This study listed the main indicators used globally 
in organ donation and transplant services publi-
shed on MedLine/PubMed, LILACS, government 
and non-governmental databases.
As the papers were read, it became clear that 
most indicators had been published by authors in 
the USA (MedLine/PubMed), followed by their 
Brazilian counterparts publishing on LILACS. 
However, most papers published on either of 
the databases had level 4 evidence (descriptive 
or qualitative studies). Additionally, the authors 
did not mention whether the indicators had been 
properly validated. However, these indicators 
were developed to assess, measure, and manage 
data related to the donor’s profile, clinical status, 
time of hospitalization, time of intubation, and 
other factors. Indicators were also used to assess 
organ characteristics, time of ischemia, organ 
size, surgical procedure, and transplant complica-
tions. Ultimately, these indicators were developed 
to improve donation and transplant processes.
It is thus recommended that other indicators 
be used in Brazil in addition to the ones in use 
today, so as to improve the organ donation and 
transplant processes currently in effect. However, 
given the level of evidence of the papers published 
in the literature and the fact that none of the 
indicators were validated, in order for those 
indicators to be used, they must be first validated.
The use of indicators in organ donation and 
transplant services is supported by the need to 
monitor and improve processes. Indicators can 
help identify issues directly impacting potential 
donor reporting and, considering the estimated 
rate of 70 pmp potential donors in Brazil and the 
goal set by the Brazilian Association for Organ 
Transplantation of achieving a rate of 15 pmp 
in successful transplants by 2015, increase the 
number of transplants performed.
Thus, the following indicators were 
recommended for Brazil:
dOnAtiOn PROcess
•	 Brain-dead donor potential per health care 
institution;
•	 Process distribution times;
•	 Donor clinical status;
•	 Time of ICU hospitalization;
•	 Patient family satisfaction;
•	 Perfusion time;
•	 Cost of transplantation;
•	 Individual surgical risk;
•	 Time on waiting list;
•	 Risk of graft failure;
•	 Organ characteristics;
•	 MELD score to assess severity of transplant 
patient.
The adoption of these indicators will certainly 
facilitate the monitoring of organ donation 
and transplant processes in Brazil, in addition 
to allowing each individual step to be further 
scrutinized. It will also improve the management 
of health care institutions with greater potential 
for donor generation and shed light on the factors 
impeding increases on the number of donors.
Transplant indicators will also reveal the 
reality faced by patients in the waiting list and 
help determine how severely ill they are and their 
surgical risk, thus helping health care teams assess 
the conditions of these patients and how likely 
they are to survive after transplantation.
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